Company logo Company name logo
Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.     |     Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors.     |     KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |     ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
tiker sep
plus stop minus
 
 
Sun Pharmaceutical Industries LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524715NSE Symbol: SUNPHARMAP/E(TTM):138.81
ISIN Demat:INE044A01036Div & Yield %:0.87EPS(TTM):13.27
Book Value(Rs):93.2373503Market Cap (rupee Cr.):441957.5Face Value(Rs):1
    
Date Headline
09-Sep-26 Sun Pharmaceutical Industries Ltd drops for fifth straight session
09-Sep-26 Sun Pharma incorporates subsidiary in IFSC, Gift City
17-Aug-26 Sun Pharma update on Lipitor antitrust litigation in US court
17-Aug-26 Sun Pharma receives favorable court ruling in Lipitor patent settlement case in US
05-Aug-26 Sun Pharmaceutical Industries receives ratings action from CRISIL
31-Jul-26 Sun Pharmaceutical Industries consolidated net profit rises 27.04% in the June 2026 quarter
31-Jul-26 Sun Pharma Q1 PAT climbs 27% YoY to Rs2,895 cr; India business drives growth
31-Jul-26 Sun Pharmaceutical Industries Ltd spurts 1.6%, up for five straight sessions
24-Jul-26 Sun Pharma receives Organon shareholders approval for merger
15-Jul-26 Sun Pharma receives approval to market semaglutide injection in South Africa
<< < 1 2 3 4   > >>